Allscripts 3.5% debentures now convertible through end of quarter

New York, June 10 - Allscripts said that its 3.5% convertible senior debentures due 2024 are now convertible into common stock and will remain so until the end of the fiscal quarter on Aug. 31.

The debentures became convertible because Allscripts stock traded above 130% of the conversion price for at least 20 out of the 30 consecutive trading days ending May 29.

The conversion ratio is 124.3781 shares per $1,000 principal amount.

Allscripts can pay cash or stock for conversions.

The company also noted that the debentures are putable at par plus accrued interest on July 15.

Allscripts is a Chicago-based healthcare technology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.